Neurones (NRO) Q4 2025 earnings summary

Executive summary

• Achieved 5.8% revenue growth in 2025, with 5.1% organic growth, outperforming a declining market.

• Net profit, group share, remained stable at €52.1 million.

• Operating profitability returned to normal in the second half of the year.

Financial highlights

• 2025 revenues reached €857.2 million, up from €810.4 million in 2024.

• Business operating profit was €84.1 million (10.4% margin), up from €82.1 million (9.6%).

• Net profit was €61.9 million (7.2% margin), compared to €63.2 million (7.8%) in 2024.

• Free cash flow totaled €62.2 million, down from €74.6 million.

• Net cash position increased to €336.6 million.

Outlook and guidance

• Confident outlook for 2026, citing strong trends in AI, data, cloud, cybersecurity, and digital.

• 2026 forecasts to be announced with Q1 revenue figures in May.

• Proposed dividend increase of 7.7% to €1.4 per share for 2025.